Standpoint Research Downgrades Medifast (MED) to Hold; Taking Profits; Possible Switch Into WTW
Tweet Send to a Friend
Standpoint Research downgraded Medifast (NYSE: MED) from Buy to Hold with a price target of $24.00.
Analyst, Ronnie Moas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Ronnie Moas ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE